SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Aguettant, an Independent French Pharmaceutical Company, and PX’Therapeutics, a French Contract Manufacturing Organization Dedicated to the Development of Recombinant Proteins, Join Forces to Boost Their Activities